Tech Company Financing Transactions
Sutro Biopharma Funding Round
Sutro Biopharma, based in South San Francisco, secured $15 million from Alta Partners and SV Health Investors.
Transaction Overview
Company Name
Announced On
3/30/2009
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Alta Partners (David Mack)
SV Health Investors (Michael Ross)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
310 Utah Ave. 150
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Sutro Biopharma, Inc. is a biopharmaceutical company that uses its patented OCFS protein synthesis technology to develop next-generation protein therapeutics for the treatment of human disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Newell
Chief Financial Officer
Edward Albini
Chief Medical Officer
Arturo Molina
Chief Scientific Officer
Trevor Hallam
Chief Technical Officer
Shabbir Anik
Vice President
Robert Kiss
Vice President
Mark Lupher
VP - Engineering
Henry Heinsohn
VP - Human Resources
Linda Fitzpatrick
VP - Operations
Nicki Vasquez
Browse more venture capital transactions:
Prev: 3/30/2009: BioVex venture capital transaction
Next: 3/31/2009: Everyday Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs